文献速递主动脉疾病

开窗与分支腔内修复治疗感染性主动脉瘤

Fenestrated and Branched Endovascular Repair for Mycotic Aortic Aneurysms.
PubMed 文献 · J Endovasc Ther · 2026-07-29

本研究回顾性分析了21例感染性复杂主动脉瘤患者接受开窗或分支腔内修复(F/BEVAR)的结果,技术成功率达95.2%,无30天死亡,3年生存率85%,但19%患者出现远期感染相关并发症,部分可半保守处理。

要点

  • F/BEVAR治疗感染性复杂主动脉瘤技术成功率高,短期结果良好。
  • 远期感染相关并发症发生率为19%,可采取抗生素或CT引导下引流处理。
  • 3年估计生存率为85%,中期结果可接受。

核心结论

  • 复杂感染性主动脉瘤的腔内修复可行,技术成功率高,短期至中期结果良好。
  • 远期感染相关并发症确实发生,但可半保守处理。

研究设计与样本

  • 单中心回顾性队列研究,纳入2017年11月至2024年8月间连续接受F/BEVAR的感染性主动脉瘤患者21例。
  • 感染性主动脉瘤诊断依据临床表现、实验室标志物和影像学发现,符合当前指南。
  • 所有患者就诊时接受广谱抗生素,术后根据情况调整为目标抗生素。

主要发现

  • 21例患者(81%男性,平均年龄73.3±5岁)中,主动脉弓4例、胸腹主动脉9例、肾旁主动脉8例。
  • 技术成功20/21(95.2%),1例IIIC型内漏,无靶血管丢失,无30天死亡。
  • 早期再干预3例(14.3%)。
  • 平均随访37.4±26.7个月,发现2例无症状肾分支闭塞,无需血运重建。
  • 4例(19%)在术后1、9、9、13个月发生感染相关并发症,2例仅抗生素保守治疗,2例联合CT引导下引流,后者分别在引流后11和31个月死亡。

临床怎么用

  • 对于涉及主动脉分支的感染性主动脉瘤,F/BEVAR可作为开放手术高危患者的替代治疗选择。
  • 术后需长期监测感染相关并发症,部分可通过抗生素或CT引导下引流进行半保守管理。

局限性

  • 单中心回顾性研究,样本量较小(21例)。
  • 随访时间有限,远期结果需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Management of mycotic complex aortic aneurysms (MAAs) involving the supra-aortic or reno-visceral vessels is highly challenging. Radical open repair carries substantial mortality and morbidity and may not always be technically feasible. Fenestrated or branched endovascular aortic repair (F/BEVAR) offers a less invasive alternative, although current experience remains limited. This study describes the outcomes of complex endovascular repair of MAAs. METHODS: This single-center retrospective cohort study included all consecutive patients with MAA who underwent F/BEVAR between November 2017 and August 2024. Mycotic aortic aneurysm diagnosis was established using a combination of clinical presentation, laboratory markers, and imaging findings according to current guidelines. All patients received broad-spectrum antibiotics at presentation before undergoing F/BEVAR, followed by targeted antibiotics as appropriate. Collected data included patient demographics, operative details, early and long-term complications, infection-related complications (IRC), all-cause mortality, and infection-related mortality. RESULTS: A total of 21 patients (81% male, mean age 73.3 ± 5 years) were treated for MAAs affecting the aortic arch (n = 4), thoracoabdominal aorta (n = 9), or pararenal aorta (n = 8). Procedures involved in situ laser fenestration (n = 13), physician-modified endografts (n = 2), off-the-shelf branched devices (n = 2), and custom-made devices (n = 4). Technical success was 20/21 (95.2%; 1 type IIIC endoleak), and no target vessel loss. No deaths occurred within 30 days postoperatively. Three early reinterventions (14.3%) were required. During a mean follow-up of 37.4 ± 26.7 months, 2 asymptomatic renal branch occlusions were detected but did not require revascularization. Four patients (19%) developed IRCs at 1, 9, 9, and 13 months after the surgery, managed either conservatively with antibiotics alone (n = 2) or combined with computed tomography (CT)-guided drainage (n = 2), both of whom died 11 and 31 months after CT-guided drainage. The 3-year Kaplan-Meier estimated survival was 85% (95% CI = 58%-95%). CONCLUSION: Complex endovascular repair of MAAs is feasible, with high technical success and favorable short- to mid-term outcomes. Late IRCs do occur in some cases, but may be managed semi-conservatively.Clinical ImpactPatients with mycotic aneurysms involving aortic side branches are at increased risk when treated with open aortic repair. These results demonstrate that fenestrated and branched endovascular techniques represent a viable therapeutic option in this challenging patient population, yielding excellent short-term and acceptable mid-term outcomes.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Legeza PT, Wanhainen A, Asciutto G, et al. Fenestrated and Branched Endovascular Repair for Mycotic Aortic Aneurysms. J Endovasc Ther. 2026. PMID: 42528162. doi:10.1177/15266028261467582

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。